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Background: Pancreatic duct ligation (PDL) has been used as a model of chronic pancreatitis and as a 
model to increase β-cell mass. However, studies in mice have demonstrated acinar regeneration after 
PDL, questioning the long-term validity of the model. We aim to elucidate whether RF-assisted 
transection (RFAT) of the main pancreatic duct is a reliable PDL model, both in short (ST, 1-month) and 
long-term (LT, 6-months) follow-ups.  Methods: Eleven pigs were subjected to RFAT. Biochemical 
(serum/peripancreatic amylase and glucose) and histological changes (including a semiautomatic 
morphometric study of over 1000 images/pancreas and IHC analysis) were evaluated after ST or LT 
follow-up and also in fresh pancreas specimens that were used as controls for 1 (n=4) and 6 months 
(n=6). Results: The distal pancreas in the ST was characterized by areas of acinar-to-ductal metaplasia 
(56%) which were significantly reduced at LT (21%) by fibrotic replacement and adipose tissue. The 
endocrine mass showed a normal increase. Conclusion: RFAT in the pig seems to be an appropriate PDL 






The conversion of exocrine acinar tissue into tubular or ductal complexes, usually known as acinar-to-
ductal metaplasia (ADM), is common in various pancreatic diseases including pancreatitis and cancer [1–
3]. Since ADM is characterized by a switch from acinar to ductal phenotype with active proliferation, and 
since metaplasic ductal lesions are frequently seen in chronic pancreatitis as well as in specimens of 
pancreatic ductal adenocarcinoma (PDAC), ADM is thought to represent a preneoplastic condition 
[1,3,4]. Even though some areas of ADM could revert to normal acinar morphology [5,6] in the absence 
of oncogenic Kras mutations or in the presence of acute pancreatitis, the transition of acinar cells into a 
duct-like state (as in ADM) has been recognized as an important early event in tumor initiation. 
 Pancreatic duct ligation (PDL) in mouse models has been extensively used as a model of 
chronic pancreatitis in order to study the evolution of ADM into PDAC [1,3,7], and also as a model of 
duct-to-islet differentiation [6,8–12] to increase beta-cell mass. However, the validity of PDL as a model 
of endocrine regeneration has now been called into question [5–7,11,13,14]. Recent results from PDL in 
mouse models have shown that some acinar cells can escape death [7] and that acinar compartment can 
regenerate in a long-term evolution after PDL (over 6 months), probably by restoration of pancreatic 
drainage [6]. Ever since the first studies on PDL in mouse models it has been said that this technique is 
difficult because its unique anatomy hampers the results [15,16]. The mouse pancreas is usually poorly 
defined and consists of three lobes (gastric, splenic and duodenal) which drain their juices via individual 
ducts only 150 µm in diameter [16,17] and there are also frequent variations in this drainage. Researchers 
usually ligate the splenic lobe from the rest of the pancreas, however this technique is challenging due to 
the small diameter of the pancreatic duct and usually requires the help of a microscope for the dissection. 
Many of these anatomical difficulties can be overcome with a large pancreas model, such as the pig 
model, in which the pancreas is large and clearly defined [18], especially if the closed proximal part 
(duodenal lobe) is preserved to avoid a difficult-to-treat steatorrhea [19]. However, in the pig model a 
larger amount of tissue must be severed and hence PDL may not be able to avoid a pancreatic fistula or to 
efficiently occlude the main pancreatic duct in the mid pancreas. 
Radiofrequency (RF) energy has been used both experimentally and clinically to manage the 
pancreatic remnant after distal pancreatectomies to seal the main and secondary pancreatic ducts [20–22]. 
In recent years, our group has tested the ability of some RF electrodes to seal vessels in the liver [23,24] 
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and kidney [25]. A recent study conducted on a porcine pancreatic model suggested that distal pancreatic 
transection by RF electrode can seal the main pancreatic duct easily and safely [22]. We have also 
demonstrated in a rat model that RF-assisted transection of the neck of the pancreas may safely seal the 
remnant distal pancreas and activate a rapid and massive exocrine atrophy without leading to necrotizing 
pancreatitis [12]. We therefore hypothesized that this technique could be used to occlude pancreatic ducts 
while severing large amounts of tissue, as in the mid pancreas of large animals. 
With the above considerations in mind, the aim of this study was to elucidate whether RF-
assisted transection (RFAT) of the main pancreatic duct in the mid porcine pancreas would be a reliable 
PDL model over a follow up period of 6 months. This technique could avoid both exocrine insufficiency 
and fistula formation without the risk of restoring pancreatic drainage.  
METHODS 
Study design and Animal model 
A total of 11 Landrace pigs were subjected to RFAT of the neck of the pancreas with different 
survival periods: Groups “Exp-1-month” (n=6) and “Exp-6-months” (n=5) with 1 and 6 months 
postoperative period (PO), respectively. Additionally, fresh pancreatic specimens from animals weighing 
40 kg (“Control-1-month”, n=4) and 120 kg (“Control-6-months”, n=6) were used as controls for 1 and 6 
months, respectively. The study was conducted according to the guidelines approved by the Government 
of Catalonia’s Animal Care Committee and as described in [22]. 
Surgical technique 
Preoperative, anaesthesia and postoperative care was provided by fully trained veterinary staff members 
as described in [22]. In order to achieve complete obstruction of the distal part (body and tail) of the 
pancreatic gland was transected including the main pancreatic duct which was severed over and below the 
portal vein according to the previous study on pancreas anatomy (Figure 1) [18]. The pancreas was 
mobilized and slightly tractioned to ensure a 5-mm minimum safe distance between RFAT site and major 
peripancreatic vessels and surrounding viscera to avoid unexpected injuries. The main pancreatic duct 
was neither identified nor sutured after transection. The transection was performed using a RF-assisted  
device (Coolinside, Apeiron Medical, Valencia, Spain) [12,22] and a silicon drain was positioned 




One and six months after the initial procedure all animals were again anesthetized, intubated and 
ventilated as described in [22]. Exploratory laparotomy was performed and the peritoneal cavity was 
assessed at necropsy. The pancreatic stump was skeletonized, photographed and the proximal and distal 
pancreas were dissected, removed and placed in 10% paraformaldehyde for further histopathologic 
processing. The animals were then sacrificed with a commercial euthanasia solution. 
Laboratory measurements 
Serum amylase and glucose levels were obtained prior to the surgical procedure, 4 hours after 
intervention, on days 3, 7, 15, 21 and 1 or 6 months PO before euthanasia. Peripancreatic fluid amylase 
concentrations were measured during laparotomy, from the drain tube on Day 3 and at necropsy. The 
surgical drain was retired in all the animals on Day 3 PO, because the output was <20 ml per day.  
Histopathologic study 
The histopathologic analysis was performed on three different slices of the pancreas. One slice of the 
proximal pancreas at 4 cm from the area of transection (PP) and two in the distal pancreas (DP): 1 cm 
next to the transection area (D1) and another before the tail (D2) (Figure 2A-1).  
Fixed samples were embedded in paraffin, cut (3 µm) and stained with hematoxylin-eosin to assess 
histological changes and also Masson’s Trichrome to observe collagen fibers. To evaluate apoptotic 
response, endocrine function and ADM immunohistochemical analysis, consecutive slices of the distal 
and proximal pancreas were incubated with primary antibodies: rabbit anti-cleaved caspase-3 (K3, 
1:1600; Cell Signalling Technology), rabbit anti-insulin (I, 1:400, Cell Signalling Technology) and mouse 
anti-cytokeratin-7 (Ck7, 1:120, Santa Cruz Biotechnology), respectively. The secondary antibody was an 
avidin-biotin complex-conjugated solution of Real DAKO (EnVision, Copenhagen, Denmark). The 
proximal pancreas was used as a control of normal pancreatic tissue within subjects. 
Morphometric analysis 
“The morphometric results of the distal part were expressed separately for D1 and D2, but 
hereinafter the mean value is referred as DP.  
Automatic acquisitions of consecutive immunohistochemistry stained slices of Ck7 and I were 
performed with a DMI-6000B Leica microscope (Leica Microsystems, Wetzlar, Germany) and Micro–
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manager software (www.micro-manager.org, San Francisco) to quantify histological changes. A FIJI 
macro was conducted to analyze: the mean area of Ck7 expression (MA-Ck7, expressed in µm2), the 
mean area of insulin expression (MA-I, expressed in µm2) and the average size of islets (µm2) (Figure 
2A-2). To adjust the staining variability, random captures of each acquisition were used to adjust hue, 
saturation and brightness, after which the segmentation algorithm for particle detection was applied. A 
segmentation process was performed on macroscopic images of the slices by 3D-DOCTOR software 
(Able Software Corp, Lexington, MA, USA) to evaluate the cross-sectional area of pancreas, 
differentiating the adipose/connective tissue, the area of pancreatic parenchyma (which excluded the 
connective capsule of the pancreas, ductal dilatation and the adipose tissue) or ADM (Figure 2A-3).  
Statistical analysis 
Kolmogorov–Smirnov Test followed by a Student’s t-Test or U Mann-Whitney Test for 
nonparametric data was performed by SPSS software. The laboratory analyses that included repeated 
measures were evaluated by the Bonferroni Test for post hoc analysis. Data were expressed as means ± 
SEM and we considered a value of p<0.05 to be statistically significant. 
RESULTS 
Intraoperative features and postoperative follow-up 
 All the animals tolerated the surgical procedure well and quickly recovered and ambulated, 
tolerating the intake without signs of relevant pancreatic disease. The animals showed a normal growth 
curve (preoperatively and pre-necropsy at 1 and 6 months, 26±8 kg, 39±12 kg and 125±14 kg, 
respectively).  
Laboratory analysis 
All the animals showed a significant increase of amylase levels (p<0.05) in both serum (4th hour 
PO and 3rd day PO) and peritoneum (3rd day PO), which returned to baseline levels on the following days, 
as previously observed in the literature [12,22] (Table 1). No animals presented any postoperative clinical 
complication or free intraabdominal fluid at necropsy, neither at 1 or 6 months. 




The histopathological study of the transection margin of the pancreas stump in the Exp-1-month 
group, showed a common pattern of coagulative necrosis surrounded by an intense fibrotic component 
which was totally replaced by fibrotic tissue in Exp-6-months. The fibrosis reaction also completely 
encircled the main and secondary pancreatic ducts, as previously described in [22].   
 
 No differences were observed between the morphometric results of D1 and D2. MA-Ck7 was 
significantly greater in DP (6.4±0.9 mm2) than PP for group Exp-1-month (4.2±0.7 mm2), which 
correlated histologically with areas of ADM. At 6 months PO, there was an increase of MA-Ck7 in group 
Control-6-months and in the PP of the animals subjected to the RFAT, while there was a significant 
decrease in MA-Ck7 in the DP (3.1±0.5 mm2) of the Exp-6-months (Figures 2-B and 3 g-i) compared to 
Exp-1-month, which was also correlated histologically with an increase in fibrotic tissue and a decrease in 
ADM areas (Figure 3 m-o). There was no evidence of significant caspase-3 activity in any of the 
pancreatic areas (Figure 3 d-f).  
Concerning the endocrine tissue, MA-I was considerably higher at 6 months than at 1 month, 
with no differences between groups, either in PP and DP or between controls and experimental groups 
(Figure 2-C). Mean islet size (Figure 2-D) also showed a progressive increase in controls and in PP of the 
RFAT group with growth of the animal. However, mean islet size of the DP in group Exp-6-months was 
significantly lower (446±108 µm2) than the PP in the same group. Mean islet size of DP in group Exp-6-
months was even lower than in Exp-1-month (780±74 µm2) and also lower than islet size in the DP in 
Control-6-months (729±149 µm2). These results were histologically consistent with a significant increase 
in small isolated clusters of β-cells in DP of the Exp-6-months (Figures 2-D2 and D3). The increase in 
these isolated endocrine cells led to a decrease in mean islet size, though macro islets of equal size were 
also identified in the proximal pancreas. 
 As the animals increased in size, we observed an increase in the cross-sectional area of pancreas 
without significant differences between the distal and the proximal pancreas (Figure 2-E). The area of the 
pancreatic parenchyma increased proportionally to the cross-sectional area of the pancreas in control 
specimens and in the PP of the animals subjected to RFAT. As expected, the DP at Exp-1-month was 
characterized by an increase in ADM (reaching 56% of the cross-sectional area at this time) with no 
evidence of preserved pancreatic parenchyma. However, this area of ADM was reduced from 1.5 ± 0.2 
cm2 at 1 month to 1.2 ± 0.2 cm2 at 6 months, in spite of the growth of the animal, and was only 21% of 
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the distal cross-sectional pancreatic area at Exp-6-months. There were no significant differences between 
the mean area of connective and adipose tissue in DP and PP in the control specimens. In contrast, an 
increase of the adipose and connective tissue was observed over the PO period in proximal and distal 
pancreas of the animals subjected to RFAT. This increase was especially significant in the DP at Exp-6-
months (80% of the cross-sectional area). 
DISCUSSION 
PDL has been extensively used to study the conversion of ADM into PDAC [1,3] as well as a method of 
duct-to-islet differentiation [6,8–12] in order to increase beta-cell mass. However, contradictory results 
have been obtained from the conventional mouse models [6,7,11,26].  
Since complete duct occlusion should prevent duct cells regenerating into acinar cells after PDL [16] and 
some morphometric results could have been biased by including injured pancreas [7,11], the present study 
implemented six key differences from conventional PDL mouse models in order to ensure efficient and 
reliable pancreatic duct occlusion and accurate evaluation: 
To start with, large animal model are used with a well-defined pancreas anatomy, and hence easy-to-
manipulate and identify, as well as being more similar to human specimens, which facilitates clinical 
translation. Secondly, we considered short (1 month PO) and long-term (6 months PO) evolution study of 
both ADM and β-cell mass, which is especially relevant since the vast majority of studies on ADM after 
PDL are restricted to short-term. Additionally, two control groups (non-PDL animals) of similar age and 
size (with survival periods equal to the experimental groups) have been used in order compare the 
histological response with healthy models. To further avoid possible restoration of pancreatic drainage in 
long-term evolution and preservation of enough tissue in the head of the pancreas to avoid cumbersome 
esteatorrea and weight loss [19] we performed complete transection of the pancreas. It is also important to 
highlight that an automatic acquisition of complete pancreatic sections of both Ck7 and insulin 
expression, including the analysis of up to 1,000 histological photographs per animal was considered to 
represent the entire pancreas volume. And this analysis is in clear contrast to other manual volumetry 
calculations which include only selected areas of the preparations [8,16]. Finally, we used a new PDL 
system based on RF-assisted transection (RFAT) which has previously been shown to avoid pancreatic 




This model has also demonstrated a complete acinar cell deletion in short and long-term evolution with 
no evidence of acinar compartment regeneration. These results are in contrast to other mouse models [6,7] 
and even pig models with simple ligation of the main pancreatic duct close to the duodenum –likely 
because of possible accessory drainages- [19,28,29] in which some regeneration of acinar tissue occurred. 
Although, the model results in the appearance of ADM in the short term RFAT group, as described after 
PDL [12,16,30], we have demonstrated the reduction of the ADM area in the long-term group compared 
to the short-term group (from 56% to 21% of the cross-sectional area), in spite of the growth of the 
animal. To our knowledge, this issue has not been demonstrated before and may consistently show that 
ADM may disappear after a reliable obstruction of the pancreatic duct in healthy conditions, as 
demonstrated by a 3-fold increase in mean preoperative weight. This is in contrast to other mouse and pig 
models in which the animals usually lost a great deal of weight even in the short term [19]. Also, instead 
of complete and persistent acinar cell disappearance, there is a normal increase of β-cell mass as the 
animal grows, which is unaltered in this PDL model. These findings are similar to those found by Rankin 
et al. [11], who demonstrated that β-cell mass and insulin contents were not altered by PDL after a 
morphometric study of the entire pancreas. Although Xu et al. [26] demonstrated a 2-fold post-PDL β-
cell expansion that plateaued within 7 days, their results were queried by other authors [11], who 
considered that their measurements could be biased by the reduced size of the injured pancreas.  
In view of the results obtained in this study, we believe that RFAT in the pig seems to be an 
appropriate PDL model without restoration of pancreatic drainage or reduction of endocrine mass. 
However, further experimental studies are needed to confirm these results.  
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Figure 1: Original illustration of a normal anatomy of the porcine pancreas and the surgical procedure 
after the first section of the pancreas according to the anatomy described by Ferrer et al. [18]. The 
“splenic” lobe (SL), corresponding to the tail and body in the human pancreas, is attached to the spleen. 
The “duodenal” lobe (DL), corresponding to the head of the pancreas, is adjacent to the duodenum, while 
the “connecting” lobe (CL), corresponding to the uncinated process is an extension of the pancreas which 
is anterior to the portal vein. There is also a “bridge” (B) of pancreatic tissue serving as an anatomical 
connection between the splenic and connecting lobes behind the portal vein. In order to achieve complete 
obstruction of the distal part (body and tail) of the pancreas, two sections were performed with the 





Figure 2. Quantitative methodology and results. (A) Schematic representation of the method applied.  A-
1) Area of analysis: "P" proximal, "D1" 1-2 cm next to the margin of transection, and "D2" next to the 
tail. A-2) Quantification of insulin with Micro-manager software: Appearance of the image after 
acquisition (A-2a), application of automatic contrast (A-2b) segmentation of the region of interest (ROI) 
(yellow, A-2c) and ROI manager (A-2d). A-3) Macroscopic study of the cross-section with 3D-DOCTOR 
for preparations "P" (A-3a), "D1" (A-3-b) and "D2" (A-3d) at 6 months PO (blue: total area, green: area 
of pancreatic parenchyma). (B) Area of Ck7 expression (mm2) for experimental group and pancreatic 
section. (C) Area of I expression (mm2) for experimental group and pancreatic section. (D) Mean islet 
size (µm2) per experimental group and pancreatic section. Insulin IHC at 6 months PO from the proximal 
(D-2) and distal pancreas (D-3) (Arrows: positive isolated of β-cell clusters). (D) Tissue distribution of 
the cross-sectional pancreatic area, which includes the area of pancreatic parenchyma, acinar-to-ductal 





Figure 3. HE, immunohistochemical staining of caspase-3 (K3), citoqueratina-7 (CK7),insulin (I) and 
Masson Trichrome  of the proximal pancreas at 6 months PO (a, d, g, j, m) and of the distal pancreas at 
one (b, e, h, k, n) and 6 months PO  (c, f, i, l, o). No apoptotic activity was observed in the distal pancreas 
one and 6 months after surgery (e-f). CK7 expression in the wall of duct-like structures significantly 
increased in the distal pancreas a month after the surgery and remained high at 6 months (h-i), but seemed 
to be replaced by fibrotic tissue at 6 months (o). Insulin expression was observed in the proximal and 
distal pancreas at one and 6 months PO (j, k, l). 
 
 
Table 1. Preoperative and postoperative amylase (peritoneal and serum) and glucose levels by group and 
throughout the postoperative period. Data expressed as mean±SEM. *p<0.05 throughout the 
postoperative period. **No peritoneal liquid was observed 6 months after the procedure. 
 
